The GSEA results showed that allograft rejection, antigen procession and presentation, autoimmune thyroid disease, the intestinal immune network for IgA production, and type I diabetes mellitus were significantly enriched in the low-AL161431.1 expression group (Figure 5D). The gene discussed is CD79A; the disease is type 1 diabetes mellitus.